Market Tracker

03/27 7:45pm ET

Hyperion Therapeutics Inc (NASDAQ:HPTX)

42.74
Delayed Data
As of Mar 27
 -0.82 / -1.88%
Today’s Change
20.23
Today|||52-Week Range
45.40
+78.08%
Year-to-Date

Today’s Trading

Previous close43.56
Today’s open43.46
Day’s range40.69 - 45.40
Volume638,532
Average volume (3 months)261,863
Market cap$887.9M
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-138.75%
Earnings growth (this year)+336.87%
Earnings growth (next 5 years)--
Revenue growth (last year)+169.13%
P/E ratioNM
Price/Sales4.33
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ATRAAtara Biotherapeutic...+1.70+4.87%
CHRSCoherus Biosciences ...+1.44+5.34%
MNTAMomenta Pharmaceutic...+0.26+1.76%
OTICOtonomy Inc+0.47+1.39%
Data as of 4:00pm ET, 03/27/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$0.22
Annual revenue (last year)$113.6M
Annual profit (last year)-$6.3M
Net profit margin-5.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Donald J. Santel
Chief Financial Officer &
Senior Vice President
Jeffrey S. Farrow
Corporate headquarters
Brisbane, California

Forecasts